Transplantation Proceedings
Volume 39, Issue 3 , Pages 591-593 , April 2007

Conversion From a Calcineurin Inhibitor-Based Immunosuppressive Regimen to Everolimus in Renal Transplant Recipients: Effect on Renal Function and Proteinuria

References 

  1. Nankivell BJ, Borrows RJ, Chir B, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003;349:2326
  2. Nankivell BJ, Borrows RJ, Fung CL-S, et al. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation. 2004;78:557
  3. Stratta P, Canavese C, Quaglia M, et al. Post-transplantation chronic renal damage in nonrenal transplant recipients. Kidney Int. 2005;68:1453
  4. Kauffman HM, Cherikh WS, et al. Post-transplant malignancies in renal transplant recipients: the past and present. Transpl Int. 2006;19:607
  5. Larson TS, Dean PG, Stegall MD, et al. Complete avoidance of calcineurin inhibitors in-renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant. 2006;6:514
  6. Boratynska M, Banasik M, Watorek E, et al. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients. Transplant Proc. 2006;38:101
  7. Straathof-Galena L, Wetzels JF, Dijkman HB, et al. Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism. Am J Transplant. 2006;6:429
  8. Letavernier E, Pe’raldi MN, Pariente A, et al. Proteinuria following a switch from calcineurin inhibitors to sirolimus. Transplantation. 2005;80:198
  9. Augustine JJ, Chang PC, Klaus TC, et al. Improved renal function after conversion from tacrolimus/sirolimus to tacrolimus/mycophenolate mofetil in kidney transplant recipients. Transplantation. 2006;81:1004
  10. Munivenkatappa R, Haririan A, Papadimitriou J. Increased epithelial cell apoptosis with de novo sirolimus immunosuppression in renal allograft DGF. (abstract) World Transplant Congress. 2006;
  11. Lorber MI, Mulgaonkar S, Butt KMH, et al. B251 Study Group Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3 year randomized multicenter phase 3 study. Transplantation. 2005;80:244

PII: S0041-1345(06)01573-9

doi: 10.1016/j.transproceed.2006.12.026

Transplantation Proceedings
Volume 39, Issue 3 , Pages 591-593 , April 2007

Article Tools